Modified stem cells tested as new weapon against spreading kidney cancer
NCT ID NCT06716853
Summary
This early-phase study tested a one-time treatment called Temferon for patients with advanced kidney cancer that had spread and stopped responding to standard therapies. Temferon uses a patient's own modified stem cells, designed to produce a cancer-fighting protein (interferon) directly at the tumor site. The main goals were to check if the treatment was safe and to see if the modified cells could reach and affect the tumors.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CLEAR CELL RCC are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Ospedale San Raffaele
Milan, Italy, 20132, Italy
Conditions
Explore the condition pages connected to this study.